{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:04:56Z","timestamp":1794474296589,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["2-SRA-2015-13-Q-R"],"award-info":[{"award-number":["2-SRA-2015-13-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Center for Diabetes Research","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12916-019-1360-3","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T01:13:43Z","timestamp":1562634823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Landmark models to define the age-adjusted risk of developing stage 1 type 1 diabetes across childhood and adolescence"],"prefix":"10.1186","volume":"17","author":[{"given":"Verena Sophia","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Knopff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Jolink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Bonifacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette-G.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"issue":"23","key":"1360_CR1","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473\u20139 \n                    https:\/\/doi.org\/10.1001\/jama.2013.6285\n                    \n                  .","journal-title":"JAMA."},{"issue":"4","key":"1360_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/MED.0000000000000173","volume":"22","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Ziegler AG. General population screening for type 1 diabetes: has its time come? Curr Opin Endocrinol Diabetes Obes. 2015;22(4):270\u20136 \n                    https:\/\/doi.org\/10.1097\/med.0000000000000173\n                    \n                  .","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"7","key":"1360_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2337\/db18-0065","volume":"67","author":"CJ Greenbaum","year":"2018","unstructured":"Greenbaum CJ, Speake C, Krischer J, Buckner J, Gottlieb PA, Schatz DA, et al. Strength in numbers: opportunities for enhancing the development of effective treatments for type 1 diabetes-the TrialNet experience. Diabetes. 2018;67(7):1216\u201325 \n                    https:\/\/doi.org\/10.2337\/db18-0065\n                    \n                  .","journal-title":"Diabetes."},{"issue":"9651","key":"1360_CR4","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1016\/S0140-6736(08)61309-4","volume":"372","author":"K Nanto-Salonen","year":"2008","unstructured":"Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet. 2008;372(9651):1746\u201355 \n                    https:\/\/doi.org\/10.1016\/s0140-6736(08)61309-4\n                    \n                  .","journal-title":"Lancet."},{"issue":"7","key":"1360_CR5","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001250050514","volume":"39","author":"M Rewers","year":"1996","unstructured":"Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807\u201312.","journal-title":"Diabetologia."},{"key":"1360_CR6","doi-asserted-by":"publisher","unstructured":"TEDDY Study Group. The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatric Diabetes. 2007;8(5):286\u201398. \n                    https:\/\/doi.org\/10.1111\/j.1399-5448.2007.00269.x\n                    \n                  .","DOI":"10.1111\/j.1399-5448.2007.00269.x"},{"issue":"5","key":"1360_CR7","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/BF00402275","volume":"36","author":"AG Ziegler","year":"1993","unstructured":"Ziegler AG, Hillebrand B, Rabl W, Mayrhofer M, Mollenhauer U, Vordemann J, et al. On the appearance of islet associated autoimmunity in offspring of dabetes mothers: a prospective study from birth. Diabetologia. 1993;36(5):402\u20138.","journal-title":"Diabetologia."},{"issue":"6","key":"1360_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2337\/dc10-2456","volume":"34","author":"S Hummel","year":"2011","unstructured":"Hummel S, Pfluger M, Hummel M, Bonifacio E, Ziegler AG. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care. 2011;34(6):1301\u20135 \n                    https:\/\/doi.org\/10.2337\/dc10-2456\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"7","key":"1360_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/pedi.12151","volume":"15","author":"M Lundgren","year":"2014","unstructured":"Lundgren M, Sahlin \u00c5, Svensson C, Carlsson A, Cedervall E, J\u00f6nsson B, et al. Reduced morbidity at diagnosis and improved glycemic control in children previously enrolled in DiPiS follow-up. Pediatr Diabetes. 2014;15(7):494\u2013501 \n                    https:\/\/doi.org\/10.1111\/pedi.12151\n                    \n                  .","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"1360_CR10","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark \u00c5, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964\u201374.","journal-title":"Diabetes Care"},{"issue":"5","key":"1360_CR11","doi-asserted-by":"publisher","first-page":"e011144","DOI":"10.1136\/bmjopen-2016-011144","volume":"6","author":"J Raab","year":"2016","unstructured":"Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, et al. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016;6(5):e011144 \n                    https:\/\/doi.org\/10.1136\/bmjopen-2016-011144\n                    \n                  .","journal-title":"BMJ Open"},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"28085","DOI":"10.1016\/j.atherosclerosis.2018.11.011","volume":"280","author":"O Kordonouri","year":"2018","unstructured":"Kordonouri O, Lange K, Boettcher I, Christoph J, Marquardt E, Tombois C, et al. New approach for detection of LDL-hypercholesterolemia in the pediatric population: the Fr1dolin-trial in Lower Saxony, Germany. Atherosclerosis. 2018;280:28085\u201391 \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.11.011\n                    \n                  .","journal-title":"Atherosclerosis"},{"issue":"7","key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00125-012-2472-x","volume":"55","author":"AG Ziegler","year":"2012","unstructured":"Ziegler AG, Bonifacio E. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia. 2012;55(7):1937\u201343 \n                    https:\/\/doi.org\/10.1007\/s00125-012-2472-x\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"5","key":"1360_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark A, Hagopian WA, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015;58(5):980\u20137 \n                    https:\/\/doi.org\/10.1007\/s00125-015-3514-y\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"7","key":"1360_CR15","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1007\/s00125-012-2523-3","volume":"55","author":"V Parikka","year":"2012","unstructured":"Parikka V, Nanto-Salonen K, Saarinen M, Simell T, Ilonen J, Hyoty H, et al. Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia. 2012;55(7):1926\u201336 \n                    https:\/\/doi.org\/10.1007\/s00125-012-2523-3\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"2","key":"1360_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s00125-006-0546-3","volume":"50","author":"S Hummel","year":"2007","unstructured":"Hummel S, Hummel M, Banholzer J, Hanak D, Mollenhauer U, Bonifacio E, et al. Development of autoimmunity to transglutaminase C in children of patients with type 1 diabetes: relationship to islet autoantibodies and infant feeding. Diabetologia. 2007;50(2):390\u20134 \n                    https:\/\/doi.org\/10.1007\/s00125-006-0546-3\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"3","key":"1360_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","volume":"48","author":"AG Ziegler","year":"1999","unstructured":"Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes. 1999;48(3):460\u20138.","journal-title":"Diabetes."},{"issue":"9","key":"1360_CR18","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s00125-009-1438-0","volume":"52","author":"P Achenbach","year":"2009","unstructured":"Achenbach P, Lampasona V, Landherr U, Koczwara K, Krause S, Grallert H, et al. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk. Diabetologia. 2009;52(9):1881\u20138 \n                    https:\/\/doi.org\/10.1007\/s00125-009-1438-0\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"6","key":"1360_CR19","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s001250051214","volume":"42","author":"M Schenker","year":"1999","unstructured":"Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert ED, et al. Early expression and high prevalence of islet autoantibodies for DR3\/4 heterozygous and DR4\/4 homozygous offspring of parents with type I diabetes: the German BABYDIAB study. Diabetologia. 1999;42(6):671\u20137 \n                    https:\/\/doi.org\/10.1007\/s001250051214\n                    \n                  .","journal-title":"Diabetologia."},{"key":"1360_CR20","doi-asserted-by":"publisher","unstructured":"Puavilai G, Chanprasertyotin S, Sriphrapradaeng A. Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization. Diabetes Res Clin Pract. 1999;44(1):21\u20136. \n                    https:\/\/doi.org\/10.1016\/S0168-8227(99)00008-X\n                    \n                  .","DOI":"10.1016\/S0168-8227(99)00008-X"},{"issue":"2","key":"1360_CR21","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s12561-016-9157-9","volume":"9","author":"H Putter","year":"2017","unstructured":"Putter H, van Houwelingen HC. Understanding landmarking and its relation with time-dependent Cox regression. Stat Biosci. 2017;9(2):489\u2013503 \n                    https:\/\/doi.org\/10.1007\/s12561-016-9157-9\n                    \n                  .","journal-title":"Stat Biosci"},{"key":"1360_CR22","doi-asserted-by":"crossref","unstructured":"van Houwelingen H, Putter H. Dynamic prediction in clinical survival analysis. Boca Raton: CRC Press, Inc; 2011.","DOI":"10.1201\/b11311"},{"issue":"368","key":"1360_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/01621459.1979.10481038","volume":"74","author":"WS Cleveland","year":"1979","unstructured":"Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc. 1979;74(368):829\u201336 \n                    https:\/\/doi.org\/10.1080\/01621459.1979.10481038\n                    \n                  .","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"1360_CR24","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857\u201372.","journal-title":"Stat Med"},{"issue":"9","key":"1360_CR25","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2337\/dc17-0238","volume":"40","author":"JP Krischer","year":"2017","unstructured":"Krischer JP, Lynch KF, Lernmark A, Hagopian WA, Rewers MJ, She JX, et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care. 2017;40(9):1194\u2013202 \n                    https:\/\/doi.org\/10.2337\/dc17-0238\n                    \n                  .","journal-title":"Diabetes Care"},{"issue":"7","key":"1360_CR26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00125-008-1022-z","volume":"51","author":"E Bonifacio","year":"2008","unstructured":"Bonifacio E, Pfluger M, Marienfeld S, Winkler C, Hummel M, Ziegler AG. Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA(1c). Diabetologia. 2008;51(7):1245\u201352 \n                    https:\/\/doi.org\/10.1007\/s00125-008-1022-z\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"7","key":"1360_CR27","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00125-012-2472-x","volume":"55","author":"A-G Ziegler","year":"2012","unstructured":"Ziegler A-G, Bonifacio E. Group tB-BS. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia. 2012;55(7):1937\u201343 \n                    https:\/\/doi.org\/10.1007\/s00125-012-2472-x\n                    \n                  .","journal-title":"Diabetologia."},{"issue":"5","key":"1360_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00125-006-0160-4","volume":"49","author":"PJ Bingley","year":"2006","unstructured":"Bingley PJ, Gale EAM, Group TENDIT. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia. 2006;49(5):881\u201390 \n                    https:\/\/doi.org\/10.1007\/s00125-006-0160-4\n                    \n                  .","journal-title":"Diabetologia."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-019-1360-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-019-1360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:09:54Z","timestamp":1594163394000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-019-1360-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1186\/s12916-019-1360-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The BABYDIAB and the BABYDIET studies were approved by the ethics committee of Bavaria, Germany (Bayerische Landes\u00e4rztekammer no. 95357 and Ludwig-Maximilians University no. 329\/00, respectively) and were performed in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participating families.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}